Advertisement

Alere Inc., a healthcare management firm in Waltham, has licensed from Foster City, Calif.-based VitaPath Genetics a genetic test, in addition to gaining the right to develop other fetal health products with VitaPath.

The partnership stems from VitaPath’s spina bifida risk assessment assay, which is expected to enter the commercial market in 2012 as an identifying test of women who have a higher risk for delivering a baby with the birth defect spina bifida. The birth defect can be prevented by pregnant women with vitamins containing high doses of folic acid, according to the Spina Bifida Association website.

SOURCE

Advertisement
Advertisement